Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease

MeSH terms

• Acute Disease
• Adult
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Antirheumatic Agents / therapeutic use
• Female
• Glucocorticoids* / therapeutic use
• Humans
• Male
• Middle Aged
• Still's Disease, Adult-Onset* / drug therapy
• Treatment Outcome